All In Biotech

Free tool

FAERS Monitor: Potassium Chloride 0.22% In Sodium Chloride 0.9% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019708 or its brand name (Potassium Chloride 0.22% In Sodium Chloride 0.9% In Plastic Container, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.

Reports

26

Serious

13

50% of reports

Hospitalization

10

Death reported

3

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • infusion site pain4
  • product label confusion4
  • vein disorder4
  • discomfort3
  • hypokalaemia3
  • product name confusion3
  • sepsis3
  • acute kidney injury2
  • death2
  • intercepted product selection error2
  • product expiration date issue2
  • product packaging confusion2
  • abdominal pain1
  • acidosis hyperchloraemic1
  • adverse drug reaction1

Reports by year received

View as table
YearReports
20121
20137
20142
20152
20161
20171
20191
20201
20215
20222
20231
20242

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,133 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product name confusionSignal32232.8769.04,634
acidosis hyperchloraemic11365.6199.5340
intercepted product selection error21245.8328.61,396
product expiration date issue21156.8305.21,297
product packaging confusion2667.0176.0747
vein disorderSignal4647.2262.61,974
product label confusionSignal4555.6225.51,694
infusion site painSignal4251.2102.0762
hypokalaemiaSignal352.618.1105
discomfortSignal339.813.778
sepsisSignal321.87.541
acute kidney injury210.62.89
adverse drug reaction19.01.31
abdominal pain13.50.50
death21.90.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.